In order to view this page properly, you need to have Javascript enabled.
Current Issue
Archives
Upcoming Issues
Advisory Board
Contribute
Meet the Staff
Features
News
Products
Features
News
Products
Features
News
Products
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News
New Products
Cell-Based Technology
Chemistry/Pharmacology
HTS Automation
Informatics
Instrumentation
Resources
Glossary
Associations
Calendar
Webcasts
White Papers
Job Search
NEWSLETTERS
|
WHITE PAPERS
|
SUBSCRIBE
|
ADVERTISE
|
CONTACT US
|
ABOUT US
Today is:
News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News
SITE SPONSORS
Advertise with Us
Browse Drug Discovery News:
MorphoSys And Absynth Sign Collaboration
MorphoSys has signed a license and collaboration agreement with UK-based Absynth Biologics, providing access to novel target molecules associated with
Staphylococcus aureus
infections including MRSA (methicillin-resistant
S. aureus
).
continue
Researchers Develop Drugs Targeting the Untouchables
After decades of dreaming the drug developer’s impossible dream, scientists are finally reporting progress in making drugs that target the the hundreds of thousands of proteins that many scientists considered to be “undruggable".
continue
MedImmune Evaluating Phylogica's Peptide Library
Phylogica Ltd, a public Australian drug discovery company, announced that they have entered into an agreement with MedImmune to evaluate Phylogica’s proprietary Phylomer peptide library for novel antimicrobial peptides.
continue
Rochester Scientist Discovers New Adjuvant
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.
continue
Herpes Protein Allows Cellular Invasion
The mechanism by which a herpes virus invades cells has always been a mystery to scientists, but now researchers have revealed that the unusual structure of a key member of the protein complex allows the herpes virus to enter cells.
continue
Biofocus Collaborating With Bristol On Neuropathic Pain
BioFocus and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).
continue
Nanoscopic Beads to Speed Up Drug Discovery
A revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs – bringing vital new treatments to patients much more quickly.
continue
Screening Method for Extra Large Libraries Developed
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through—time and money make it virtually impossible to screen or search through super-large libraries of potential compounds.
continue
Newly Discovered Antibodies Stop Most HIV Strains
Scientists have discovered two potent human antibodies that can stop more than 90% of known global HIV strains from infecting human cells in the laboratory, possibly leading to improved vaccines to prevent or treat HIV infection.
continue
New Treatment Slows Breast Tumor Growth By 85%
A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study.
continue
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
>> More
New Targets, Dual Agonists Increase Possibilities for Treating Diabetes
New Research May Impact Treatment of MS
Study Demonstrates Benefits of Cannabis for Pain
Lilly Halts Disappointing Alzheimer's Treatment
Jazz Pharma Drug Treats Fibromyalgia
Berries Activate Brain's Housekeeping Mechanism
Obama Stem Cell Regulations Temporarily Blocked
J&J Appoints Quality Czar
Botox Case Settled for $600M
More Problems At J&J Subsidiary
© 2010
Advantage Business Media
Privacy Policy
|
Terms & Conditions
|
Advertise with Us